ViSPad Supportive Care Study for Brain Tumor Patients - Clinical Trial
What is the Purpose of this Study?
We are doing this study to find out the practicality of using a new program called ViSPad on an electronic tablet. We want to know if this program can help reduce anxiety for cancer patients who are having imaging scans done (for example, MRI).
What is the Condition Being Studied?
Brain Tumor Imaging
Who Can Participate in the Study?
Adults ages 18+ who:
- Are scheduled to have MRI scans
- Have a histological (a microscopic study of the structure of a tumor) diagnosis of primary or metastatic brain tumor
- Are able to speak, read, and write in English
For more information about who can be in this study, please contact the study team at 919-684-5301.
Age Group
Adults
What is Involved?
If you chose to be in this study, you will:
- Complete a Hospital Anxiety and Depression Scale (HADS) questionnaire before your first MRI scan
- Complete ViSPad (a series of images viewed on an electronic tablet) before your second MRI scan
- Complete HADS after ViSPad and before your second MRI scan
- Complete an Exit Survey after your second MRI scan
Study Details
Full Title
A Feasibility Study for Heavy Compression Static Images (ViSPad) for the Reduction of Anxiety, Depression, and Intrusive Memories in Brain Tumor Patients Undergoing Standard of Care Imaging
Principal Investigator
Neuro-oncologist
Protocol Number
IRB:
PRO00110745
Phase
Phase
Pilot
Enrollment Status
Open for Enrollment
Participate
Call 919-684-5301